{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T13:42:46Z","timestamp":1770039766545,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,27]],"date-time":"2024-10-27T00:00:00Z","timestamp":1729987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,27]],"date-time":"2024-10-27T00:00:00Z","timestamp":1729987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170666"],"award-info":[{"award-number":["82170666"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-77105-2","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T08:43:52Z","timestamp":1730105032000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Causal relationships between three plasma proteins and non-alcoholic fatty liver disease, mediated by Epstein-Barr virus EA-D antibody levels: a mendelian randomization study"],"prefix":"10.1038","volume":"14","author":[{"given":"Ruijie","family":"Ming","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongjun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,27]]},"reference":[{"issue":"4","key":"77105_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","volume":"18","author":"DQ Huang","year":"2021","unstructured":"Huang, D. Q., El-Serag, H. B. & Loomba, R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 18 (4), 223\u2013238 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"77105_CR2","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani, N. et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the study of Liver diseases. Hepatology. 67 (1), 328\u2013357 (2018).","journal-title":"Hepatology"},{"issue":"2","key":"77105_CR3","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jhep.2021.09.007","volume":"76","author":"F Foerster","year":"2022","unstructured":"Foerster, F. et al. NAFLD-driven HCC: safety and efficacy of current and emerging treatment options. J. Hepatol. 76 (2), 446\u2013457 (2022).","journal-title":"J. Hepatol."},{"issue":"3","key":"77105_CR4","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.cgh.2020.05.064","volume":"19","author":"ZM Younossi","year":"2021","unstructured":"Younossi, Z. M. et al. Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States. Clin. Gastroenterol. Hepatol. 19 (3), 580\u2013589e5 (2021).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"77105_CR5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1146\/annurev-med-042220-020407","volume":"73","author":"Y Saiman","year":"2022","unstructured":"Saiman, Y., Duarte-Rojo, A. & Rinella, M. E. Fatty liver disease: diagnosis and stratification. Annu. Rev. Med. 73, 529\u2013544 (2022).","journal-title":"Annu. Rev. Med."},{"key":"77105_CR6","doi-asserted-by":"publisher","first-page":"14357","DOI":"10.1038\/ncomms14357","volume":"8","author":"K Suhre","year":"2017","unstructured":"Suhre, K. et al. Connecting genetic risk to disease end points through the human blood plasma proteome. Nat. Commun. 8, 14357 (2017).","journal-title":"Nat. Commun."},{"issue":"1","key":"77105_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrd.2016.230","volume":"16","author":"R Santos","year":"2017","unstructured":"Santos, R. et al. A comprehensive map of molecular drug targets. Nat. Rev. Drug Discov. 16 (1), 19\u201334 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"77105_CR8","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1002\/hep.32620","volume":"77","author":"V Indira Chandran","year":"2023","unstructured":"Indira Chandran, V. et al. Circulating TREM2 as a noninvasive diagnostic biomarker for NASH in patients with elevated liver stiffness. Hepatology. 77 (2), 558\u2013572 (2023).","journal-title":"Hepatology"},{"key":"77105_CR9","doi-asserted-by":"crossref","unstructured":"Qu, X. & Donnelly, R. Sex hormone-binding globulin (SHBG) as an early biomarker and therapeutic target in polycystic ovary syndrome. Int. J. Mol. Sci., 21(21), 8191 (2020).","DOI":"10.3390\/ijms21218191"},{"issue":"47","key":"77105_CR10","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1093\/eurheartj\/ehad736","volume":"44","author":"SC Larsson","year":"2023","unstructured":"Larsson, S. C., Butterworth, A. S. & Burgess, S. Mendelian randomization for cardiovascular diseases: principles and applications. Eur. Heart J. 44 (47), 4913\u20134924 (2023).","journal-title":"Eur. Heart J."},{"issue":"8","key":"77105_CR11","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1371\/journal.pmed.0050177","volume":"5","author":"NA Sheehan","year":"2008","unstructured":"Sheehan, N. A. et al. Mendelian randomisation and causal inference in observational epidemiology. PLoS Med. 5 (8), e177 (2008).","journal-title":"PLoS Med."},{"key":"77105_CR12","doi-asserted-by":"crossref","unstructured":"Hakonarson, H., Gulcher, J. R. & Stefansson, K. deCODE Genet. Inc. Pharmacogenomics 4(2): 209\u2013215. (2003).","DOI":"10.1517\/phgs.4.2.209.22627"},{"issue":"12","key":"77105_CR13","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","volume":"53","author":"E Ferkingstad","year":"2021","unstructured":"Ferkingstad, E. et al. Large-scale integration of the plasma proteome with genetics and disease. Nat. Genet. 53 (12), 1712\u20131721 (2021).","journal-title":"Nat. Genet."},{"issue":"7944","key":"77105_CR14","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki, M. I. et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 613 (7944), 508\u2013518 (2023).","journal-title":"Nature"},{"issue":"11","key":"77105_CR15","doi-asserted-by":"publisher","first-page":"ofaa450","DOI":"10.1093\/ofid\/ofaa450","volume":"7","author":"G Butler-Laporte","year":"2020","unstructured":"Butler-Laporte, G. et al. Genetic determinants of antibody-mediated Immune responses to infectious diseases agents: a genome-wide and HLA Association Study. Open. Forum Infect. Dis. 7 (11), ofaa450 (2020).","journal-title":"Open. Forum Infect. Dis."},{"issue":"3","key":"77105_CR16","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/ije\/dyq151","volume":"40","author":"BL Pierce","year":"2011","unstructured":"Pierce, B. L., Ahsan, H. & Vanderweele, T. J. Power and instrument strength requirements for mendelian randomization studies using multiple genetic variants. Int. J. Epidemiol. 40 (3), 740\u2013752 (2011).","journal-title":"Int. J. Epidemiol."},{"issue":"1","key":"77105_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12944-024-02134-9","volume":"23","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. The causal relationship and potential mediators between plasma lipids and atopic dermatitis: a bidirectional two-sample, two-step mendelian randomization. Lipids Health Dis. 23 (1), 191 (2024).","journal-title":"Lipids Health Dis."},{"issue":"4","key":"77105_CR18","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1007\/s11357-022-00602-7","volume":"44","author":"J Luo","year":"2022","unstructured":"Luo, J. et al. Systemic inflammatory markers in relation to cognitive function and measures of brain atrophy: a mendelian randomization study. Geroscience. 44 (4), 2259\u20132270 (2022).","journal-title":"Geroscience"},{"key":"77105_CR19","doi-asserted-by":"publisher","first-page":"1221272","DOI":"10.3389\/fnagi.2023.1221272","volume":"15","author":"M Yu","year":"2023","unstructured":"Yu, M. et al. Inflammatory biomarkers and delirium: a mendelian randomization study. Front. Aging Neurosci. 15, 1221272 (2023).","journal-title":"Front. Aging Neurosci."},{"issue":"3","key":"77105_CR20","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess, S. & Thompson, S. G. Avoiding bias from weak instruments in mendelian randomization studies. Int. J. Epidemiol. 40 (3), 755\u2013764 (2011).","journal-title":"Int. J. Epidemiol."},{"issue":"11","key":"77105_CR21","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/sim.7221","volume":"36","author":"J Bowden","year":"2017","unstructured":"Bowden, J. et al. A framework for the investigation of pleiotropy in two-sample summary data mendelian randomization. Stat. Med. 36 (11), 1783\u20131802 (2017).","journal-title":"Stat. Med."},{"issue":"1","key":"77105_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12916-021-02193-0","volume":"20","author":"E Bouras","year":"2022","unstructured":"Bouras, E. et al. Circulating inflammatory cytokines and risk of five cancers: a mendelian randomization analysis. BMC Med. 20 (1), 3 (2022).","journal-title":"BMC Med."},{"key":"77105_CR23","doi-asserted-by":"crossref","unstructured":"Hemani, G. et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife 7, e34408 (2018).","DOI":"10.7554\/eLife.34408"},{"issue":"1","key":"77105_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s40120-021-00310-y","volume":"11","author":"MJ Shu","year":"2022","unstructured":"Shu, M. J. et al. Migraine and ischemic stroke: a mendelian randomization study. Neurol. Ther. 11 (1), 237\u2013246 (2022).","journal-title":"Neurol. Ther."},{"key":"77105_CR25","doi-asserted-by":"publisher","first-page":"1319127","DOI":"10.3389\/fimmu.2023.1319127","volume":"14","author":"Y Jin","year":"2023","unstructured":"Jin, Y. et al. Causal effects and immune cell mediators between prescription analgesic use and risk of infectious diseases: a mendelian randomization study. Front. Immunol. 14, 1319127 (2023).","journal-title":"Front. Immunol."},{"issue":"11","key":"77105_CR26","doi-asserted-by":"publisher","first-page":"e1007081","DOI":"10.1371\/journal.pgen.1007081","volume":"13","author":"G Hemani","year":"2017","unstructured":"Hemani, G., Tilling, K. & Davey Smith, G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 13 (11), e1007081 (2017).","journal-title":"PLoS Genet."},{"issue":"5","key":"77105_CR27","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10654-021-00757-1","volume":"36","author":"AR Carter","year":"2021","unstructured":"Carter, A. R. et al. Mendelian randomisation for mediation analysis: current methods and challenges for implementation. Eur. J. Epidemiol. 36 (5), 465\u2013478 (2021).","journal-title":"Eur. J. Epidemiol."},{"issue":"6","key":"77105_CR28","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","volume":"10","author":"QM Anstee","year":"2013","unstructured":"Anstee, Q. M., Targher, G. & Day, C. P. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat. Rev. Gastroenterol. Hepatol. 10 (6), 330\u2013344 (2013).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"11","key":"77105_CR29","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1038\/s41588-022-01199-5","volume":"54","author":"G Sveinbjornsson","year":"2022","unstructured":"Sveinbjornsson, G. et al. Multiomics study of nonalcoholic fatty liver disease. Nat. Genet. 54 (11), 1652\u20131663 (2022).","journal-title":"Nat. Genet."},{"issue":"4","key":"77105_CR30","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jhep.2022.11.029","volume":"78","author":"AJ Sanyal","year":"2023","unstructured":"Sanyal, A. J. et al. Defining the serum proteomic signature of hepatic steatosis, inflammation, ballooning and fibrosis in non-alcoholic fatty liver disease. J. Hepatol. 78 (4), 693\u2013703 (2023).","journal-title":"J. Hepatol."},{"issue":"4","key":"77105_CR31","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s42255-023-00775-1","volume":"5","author":"O Govaere","year":"2023","unstructured":"Govaere, O. et al. A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures. Nat. Metab. 5 (4), 572\u2013578 (2023).","journal-title":"Nat. Metab."},{"issue":"1","key":"77105_CR32","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/hep4.1696","volume":"6","author":"H Takahashi","year":"2022","unstructured":"Takahashi, H. et al. Ipragliflozin improves the hepatic outcomes of patients with diabetes with NAFLD. Hepatol. Commun. 6 (1), 120\u2013132 (2022).","journal-title":"Hepatol. Commun."},{"issue":"2","key":"77105_CR33","doi-asserted-by":"publisher","first-page":"e520","DOI":"10.1210\/clinem\/dgaa792","volume":"106","author":"TL Stanley","year":"2021","unstructured":"Stanley, T. L. et al. Relationship of IGF-1 and IGF-binding proteins to disease severity and glycemia in nonalcoholic fatty liver disease. J. Clin. Endocrinol. Metab. 106 (2), e520\u2013e533 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"77105_CR34","doi-asserted-by":"publisher","first-page":"880298","DOI":"10.3389\/fimmu.2022.880298","volume":"13","author":"Y Duan","year":"2022","unstructured":"Duan, Y. et al. Association of inflammatory cytokines with non-alcoholic fatty liver disease. Front. Immunol. 13, 880298 (2022).","journal-title":"Front. Immunol."},{"issue":"3","key":"77105_CR35","doi-asserted-by":"publisher","first-page":"e8793","DOI":"10.15252\/msb.20188793","volume":"15","author":"L Niu","year":"2019","unstructured":"Niu, L. et al. Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease. Mol. Syst. Biol. 15 (3), e8793 (2019).","journal-title":"Mol. Syst. Biol."},{"issue":"11","key":"77105_CR36","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/nrgastro.2013.182","volume":"10","author":"QM Anstee","year":"2013","unstructured":"Anstee, Q. M. & Day, C. P. The genetics of NAFLD. Nat. Rev. Gastroenterol. Hepatol. 10 (11), 645\u2013655 (2013).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"22","key":"77105_CR37","doi-asserted-by":"publisher","first-page":"12445","DOI":"10.1073\/pnas.93.22.12445","volume":"93","author":"V Groh","year":"1996","unstructured":"Groh, V. et al. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc. Natl. Acad. Sci. USA. 93 (22), 12445\u201312450 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"77105_CR38","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1111\/j.1349-7006.2008.00859.x","volume":"99","author":"K Kohga","year":"2008","unstructured":"Kohga, K. et al. Serum levels of soluble major histocompatibility complex (MHC) class I-related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma. Cancer Sci. 99 (8), 1643\u20131649 (2008).","journal-title":"Cancer Sci."},{"issue":"1","key":"77105_CR39","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/hep.23253","volume":"51","author":"A Kahraman","year":"2010","unstructured":"Kahraman, A. et al. Major histocompatibility complex class I-related chains a and B (MIC A\/B): a novel role in nonalcoholic steatohepatitis. Hepatology. 51 (1), 92\u2013102 (2010).","journal-title":"Hepatology"},{"issue":"3","key":"77105_CR40","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/j.1478-3231.2011.02608.x","volume":"32","author":"A Kahraman","year":"2012","unstructured":"Kahraman, A. et al. Role of stress-induced NKG2D ligands in liver diseases. Liver Int. 32 (3), 370\u2013382 (2012).","journal-title":"Liver Int."},{"issue":"26","key":"77105_CR41","doi-asserted-by":"publisher","first-page":"23157","DOI":"10.1074\/jbc.M202529200","volume":"277","author":"T Chavakis","year":"2002","unstructured":"Chavakis, T. et al. Inhibition of platelet adhesion and aggregation by a defined region (Gly-486-Lys-502) of high molecular weight kininogen. J. Biol. Chem. 277 (26), 23157\u201323164 (2002).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"77105_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4149\/neo_2014_001","volume":"61","author":"X He","year":"2014","unstructured":"He, X. et al. Screening differential expression of serum proteins in AFP-negative HBV-related hepatocellular carcinoma using iTRAQ -MALDI-MS\/MS. Neoplasma. 61 (1), 17\u201326 (2014).","journal-title":"Neoplasma"},{"issue":"7","key":"77105_CR43","first-page":"621","volume":"22","author":"AHA Abdel Wahab","year":"2017","unstructured":"Abdel Wahab, A. H. A. et al. Identification of circulating protein biomarkers in patients with hepatocellular carcinoma concomitantly infected with chronic hepatitis C virus. Biomarkers. 22 (7), 621\u2013628 (2017).","journal-title":"Biomarkers"},{"issue":"2","key":"77105_CR44","first-page":"288","volume":"81","author":"L Yong","year":"2018","unstructured":"Yong, L., Guang, B. & Yan, L. Bioinformatic analysis of differentially expressed genes involved in the hepatitis B virus-associated acute liver failure. Acta Gastroenterol. Belg. 81 (2), 288\u2013294 (2018).","journal-title":"Acta Gastroenterol. Belg."},{"key":"77105_CR45","doi-asserted-by":"publisher","first-page":"104694","DOI":"10.1016\/j.ebiom.2023.104694","volume":"94","author":"B Zhang","year":"2023","unstructured":"Zhang, B. et al. An HBV susceptibility variant of KNG1 modulates the therapeutic effects of interferons \u03b1 and \u03bb1 in HBV infection by promoting MAVS lysosomal degradation. EBioMedicine. 94, 104694 (2023).","journal-title":"EBioMedicine"},{"issue":"1","key":"77105_CR46","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1038\/s41467-018-04586-x","volume":"9","author":"W Zheng","year":"2018","unstructured":"Zheng, W. et al. Hydrophobic pore gates regulate ion permeation in polycystic kidney disease 2 and 2L1 channels. Nat. Commun. 9 (1), 2302 (2018).","journal-title":"Nat. Commun."},{"issue":"5","key":"77105_CR47","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1159\/000169141","volume":"17","author":"A Bozza","year":"1997","unstructured":"Bozza, A. et al. Autosomal dominant polycystic kidney disease linked to PKD2 locus in a family with severe extrarenal manifestations. Am. J. Nephrol. 17 (5), 458\u2013461 (1997).","journal-title":"Am. J. Nephrol."},{"issue":"3","key":"77105_CR48","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.cellsig.2006.09.005","volume":"19","author":"L Tsiokas","year":"2007","unstructured":"Tsiokas, L., Kim, S. & Ong, E. C. Cell biology of polycystin-2. Cell. Signal. 19 (3), 444\u2013453 (2007).","journal-title":"Cell. Signal."},{"key":"77105_CR49","doi-asserted-by":"publisher","first-page":"1142296","DOI":"10.3389\/fcvm.2023.1142296","volume":"10","author":"S Mo","year":"2023","unstructured":"Mo, S. et al. Identification of common signature genes and pathways underlying the pathogenesis association between nonalcoholic fatty liver disease and atherosclerosis. Front. Cardiovasc. Med. 10, 1142296 (2023).","journal-title":"Front. Cardiovasc. Med."},{"issue":"2","key":"77105_CR50","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jiph.2019.11.009","volume":"13","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Effects of Epstein-Barr virus infection on liver function in children. J. Infect. Public. Health. 13 (2), 260\u2013265 (2020).","journal-title":"J. Infect. Public. Health"},{"issue":"1","key":"77105_CR51","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13052-023-01546-0","volume":"49","author":"S Mao","year":"2023","unstructured":"Mao, S., Wu, L. & Shi, W. Risk prediction for liver injury in Epstein-Barr virus infection in pediatric respiratory tract infections. Ital. J. Pediatr. 49 (1), 138 (2023).","journal-title":"Ital. J. Pediatr."},{"issue":"16","key":"77105_CR52","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1182\/blood.2019000933","volume":"135","author":"C Melani","year":"2020","unstructured":"Melani, C., Jaffe, E. S. & Wilson, W. H. Pathobiology and treatment of lymphomatoid granulomatosis, a rare EBV-driven disorder. Blood. 135 (16), 1344\u20131352 (2020).","journal-title":"Blood"},{"issue":"33","key":"77105_CR53","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.3748\/wjg.v16.i33.4130","volume":"16","author":"M Petrova","year":"2010","unstructured":"Petrova, M. & Kamburov, V. Epstein-Barr virus: silent companion or causative agent of chronic liver disease? World J. Gastroenterol. 16 (33), 4130\u20134134 (2010).","journal-title":"World J. Gastroenterol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77105-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77105-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77105-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T08:52:47Z","timestamp":1730105567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77105-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,27]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["77105"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-77105-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,27]]},"assertion":[{"value":"9 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25644"}}